Sign in

CIK 0001802665

  • Large accelerated filer

Harmony Biosciences Holdings, Inc.

Sign in to watch
Ticker
HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822279923
Phone
+1 484-539-9800
Business address
630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,108,586
in 2 filings

Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Budur Kumar −$3.1M CHIEF MEDICAL OFFICER sold 85% of stake
Date Insider Transaction Shares Price Value Owned after
2021-05-20 Sender Gary Director Grant or award · Stock Option +13,333 13,333
2021-05-20 Nielsen Jack Director Grant or award · Stock Option +7,246 7,246
2021-05-20 Motley Eric L Director Grant or award · Stock Option +7,246 7,246
2021-05-20 Graf R. Mark Director Grant or award · Stock Option +7,246 7,246
2021-05-20 Sabater Juan A. Director Grant or award · Stock Option +7,246 7,246
2021-03-29 Kapadia Sandip Chief Financial Officer Grant or award · Restricted Stock Units +60,000 60,000
2021-03-29 Kapadia Sandip Chief Financial Officer Grant or award · Stock Option +230,000 230,000
2020-11-11 Motley Eric L Director Grant or award · Stock Option +4,604 4,604
2020-11-11 Graf R. Mark Director Grant or award · Stock Option +4,604 4,604
2020-08-26 Nielsen Jack Director Purchase +3,922 $34.30 $135K 42,702
2020-08-25 Nielsen Jack Director Purchase +823 $34.20 $28K 38,780
2020-08-24 Nielsen Jack Director Purchase +3,057 $34.30 $105K 37,957
2020-08-21 Marshman Fund Trust II 10% owner Purchase +339,476 $24.00 $8.1M 10,651,120
2020-08-21 Novo Holdings A/S 10% owner Conversion +3,622,470 3,754,973
2020-08-21 Novo Holdings A/S 10% owner Conversion · Series A Convertible Preferred Stock −25,000,000 0
2020-08-21 Novo Holdings A/S 10% owner Conversion · Series C Convertible Preferred Stock −1,860,107 0
2020-08-21 Marshman Fund Trust II 10% owner Conversion +3,379,881 3,379,881
2020-08-21 Marshman Fund Trust II 10% owner Conversion · Series A Preferred Stock −25,000,000 0
2020-08-21 Serafin Andrew Chief Business Officer Conversion +33,693 33,693
2020-08-21 Serafin Andrew Chief Business Officer Conversion · Series A Preferred Stock −200,000 0

Page 24 of 26 · 511 trades